146 related articles for article (PubMed ID: 10224450)
1. Antibodies to commercially available interferon-beta molecules in multiple sclerosis patients treated with natural interferon-beta.
Mayorga C; Luque G; Romero F; Guerrero R; Blanca M; Fernandez O
Int Arch Allergy Immunol; 1999; 118(2-4):368-71. PubMed ID: 10224450
[No Abstract] [Full Text] [Related]
2. Measurement of antibodies to interferon beta in patients with multiple sclerosis.
Pachner AR
Arch Neurol; 2001 Aug; 58(8):1299-300. PubMed ID: 11493174
[No Abstract] [Full Text] [Related]
3. [The formation and significance of antibodies to interferon beta during immunomodulating treatment of multiple sclerosis].
Bartosik-Psujek H; Stelmasiak Z
Neurol Neurochir Pol; 2004; 38(1 Suppl 1):S53-6. PubMed ID: 15045868
[TBL] [Abstract][Full Text] [Related]
4. Neutralising antibodies against interferon beta in multiple sclerosis.
Mikol D
Lancet; 2004 Jan; 363(9403):167-8; author reply 168-9. PubMed ID: 14726179
[No Abstract] [Full Text] [Related]
5. Commentary on neutralizing antibodies to interferon beta in patients with multiple sclerosis.
Whitaker JN
Arch Neurol; 2001 Aug; 58(8):1301. PubMed ID: 11493175
[No Abstract] [Full Text] [Related]
6. Neutralising antibodies against interferon beta in multiple sclerosis.
Antonelli G
Lancet; 2004 Jan; 363(9403):168; author reply 168-9. PubMed ID: 14726180
[No Abstract] [Full Text] [Related]
7. Comments on the report of the EFNS task force on IFN-beta antibodies in multiple sclerosis.
Freedman MS
Eur J Neurol; 2007 Jun; 14(6):e7; author reply e10-1. PubMed ID: 17539930
[No Abstract] [Full Text] [Related]
8. Neutralising antibodies to the beta interferons.
Coles AJ
J Neurol Neurosurg Psychiatry; 2002 Aug; 73(2):110-1. PubMed ID: 12122161
[No Abstract] [Full Text] [Related]
9. The significance of neutralizing antibodies in patients with multiple sclerosis treated with interferon beta.
Rice G
Arch Neurol; 2001 Aug; 58(8):1297-8. PubMed ID: 11493173
[No Abstract] [Full Text] [Related]
10. Correlation between anti-interferon-β binding and neutralizing antibodies in interferon-β-treated multiple sclerosis patients.
Jensen PE; Sellebjerg F; Søndergaard HB; Sørensen PS
Eur J Neurol; 2012 Oct; 19(10):1311-7. PubMed ID: 22564111
[TBL] [Abstract][Full Text] [Related]
11. Guidelines on use of anti-IFN-B antibody measurements in multiple sclerosis: report of an EFNS Task Force on IFN-B antibodies in multiple sclerosis.
Burks JS; Noronha A
Eur J Neurol; 2007 Jun; 14(6):e8-9; author reply e10-1. PubMed ID: 17539931
[No Abstract] [Full Text] [Related]
12. An improved ELISA for screening for neutralizing anti-IFN-beta antibodies in MS patients.
Pachner AR
Neurology; 2003 Nov; 61(10):1444-6. PubMed ID: 14638976
[TBL] [Abstract][Full Text] [Related]
13. Evolution of interferon-beta binding antibodies in MS patients may predict development of neutralizing antibodies.
Mayr M; Berek K; Deisenhammer F
Eur J Neurol; 2003 Jul; 10(4):462-4. PubMed ID: 12823504
[No Abstract] [Full Text] [Related]
14. The measurement of antibodies binding to IFNbeta in MS patients treated with IFNbeta.
Pachner AR; Oger J; Palace J
Neurology; 2003 Nov; 61(9 Suppl 5):S18-20. PubMed ID: 14610105
[No Abstract] [Full Text] [Related]
15. Neutralizing antibodies to interferon beta in multiple sclerosis: analytical evaluation for validation of a cytopathic effect assay.
Massart C; Gibassier J; Oger J; Le Page E; Edan G
Clin Chim Acta; 2007 Feb; 377(1-2):185-91. PubMed ID: 17123498
[TBL] [Abstract][Full Text] [Related]
16. [Beta-interferon neutralizing antibodies. Do they have clinical value in patients with multiple sclerosis?].
Romero López J; Maciñeiras Montero JL
Med Clin (Barc); 2005 Feb; 124(4):144-5. PubMed ID: 15713245
[No Abstract] [Full Text] [Related]
17. Neutralizing antibodies (NABS) and interferon beta-1b therapy of multiple sclerosis.
Horowski R; Stürzebecher CS; Kapp JF
Funct Neurol; 2001; 16(2):117-28. PubMed ID: 11495417
[No Abstract] [Full Text] [Related]
18. Strategies to treat and prevent the development of neutralizing anti-interferon-beta antibodies.
Giovannoni G
Neurology; 2003 Nov; 61(9 Suppl 5):S13-7. PubMed ID: 14610104
[TBL] [Abstract][Full Text] [Related]
19. Neutralising antibodies against interferon beta in multiple sclerosis.
Giovannoni G; Deisenhammer F
Lancet; 2004 Jan; 363(9403):166-7; author reply 168-9. PubMed ID: 14726177
[No Abstract] [Full Text] [Related]
20. Interferon inhibitory activity in patients with multiple sclerosis.
Chadha K; Weinstock-Guttman B; Zivadinov R; Bhasi K; Muhitch J; Feichter J; Tamaño-Blanco M; Abdelrahman N; Ambrus J; Munschauer F; Ramanathan M
Arch Neurol; 2006 Nov; 63(11):1579-84. PubMed ID: 17101826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
